BIPOLAR I DISORDER
Efficacy and safety data
Explore olanzapine efficacy and safety data that provided the basis for the bipolar I disorder indication for LYBALVI.1
See the DataSchizophrenia
ENLIGHTEN-1 efficacy and safety data
Explore pivotal trial data demonstrating the efficacy and safety of LYBALVI in schizophrenia.1,2
See the DataSchizophrenia
ENLIGHTEN-2 efficacy and safety data
Explore pivotal trial data evaluating the safety of LYBALVI and changes in body weight relative to olanzapine.1,3
See the Data